PEOPLE - Changes at Conmed:
This article was originally published in Clinica
Executive Summary
Conmed, a Utica, New York-headquartered firm focused on surgical devices for minimally-invasive surgery in a number of clinical areas, has promoted Joseph Corasanti to CEO. Mr Corasanti is currently the firm's president and COO and will remain in these roles. He succeeds Eugene Corasanti, who will continue to serve as chairman of the board of directors in the capacity of non-executive chairman.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.